Introduction
The Mer (Mertk, Nyk, c-Eyk) receptor tyrosine kinase is a transmembrane receptor consisting of an extracellular domain with two immunoglobulin-like and two membrane proximal fibronectin III motifs, a transmembrane region, and an intracellular tyrosine kinase domain. 1, 2 These motifs place Mer in the same tyrosine kinase subfamily as Axl 3 and Tyro-3/Sky. 4, 5 Mer, Axl, and Tyro-3 share the same ligand, 6, 7 Gas6, which has significant homology to the negative co-regulator of the blood coagulation pathway Protein S. 8 Abnormal expression or activity of the Mer tyrosine kinase may play a role in tumorigenesis. The avian Mer ortholog, eyk, was discovered first as the oncogene in acute avian retrovirus RPL30. The constitutively active tyrosine kinase domain of v-eyk causes fibrosarcomas, endotheliomas and visceral lymphomatosis in chickens.
9,10
Overexpression of murine Mer tyrosine kinase transforms BaF3 lymphocytes 11 and overexpression of human Mer transforms NIH3T3 cells. 12 Several human cancers overexpress Mer, including mantle cell lymphomas, 13 alveolar rhabdomyosarcomas, 14 gastric cancer, 15 and pituitary adenomas. 16 Mer is also ectopically expressed in pediatric T cell acute lymphoblastic leukemia, 17 and a Mer transgenic mouse model with ectopic expression of Mer in thymocytes and lymphocytes develops T cell lymphoblastic leukemia/lymphoma. 18 Axl and Tyro-3 also transform cells in vitro 3, 4 and are overexpressed in a spectrum of human cancers.
In addition to abnormal function of Mer in cancer, a physiologic role for Mer in has recently been described in macrophages. Mer, Axl, and Tyro-3 have been shown to limit the extent of macrophage activation in response to an immune stimulus. 19, 20 Mer also plays a significant role in the ability of macrophages to clear apoptotic cells 21 and this deficiency has been linked to the development of autoimmune disorders in mice.
Lack of Mer receptor causing defective macrophage apoptotic cell clearance in the Royal
College of Surgeons (RCS) rat has also been implicated in the development of retinitis pigmentosa. 22 Interestingly, Mer gene mutations have been defined in a subset of humans with retinitis pigmentosa. 23 Furthermore, a physiologic role for the Mer tyrosine kinase has been described for the normal function of platelets. The interaction of Gas6 with Mer, Axl, and Tyro-3 is important in platelet degranulation and aggregation in response to known agonists.
Mice lacking either Gas6 or Mer protein have impaired platelet aggregation in vitro and
diminished clot stability in vivo. [24] [25] [26] A delicate balance of ligand interaction with a tyrosine kinase receptor is necessary to maintain normal tyrosine kinase function without causing overactivation, which could result in human disease. One means of regulating tyrosine kinase activation is through proteolytic cleavage of the membrane-bound protein. Through this process, the total number of membrane-bound receptors is reduced. In addition, the soluble cleavage product may function as a decoy receptor and sequester ligand. 27 In this study, we show that the Mer receptor tyrosine kinase can be cleaved by a metalloprotease, and 
Materials and Methods

Analysis of Mer protein in cell lysates and conditioned medium
To detect constitutively shed Mer ectodomain, J774, HEK293, A549, and microvascular endothelial cells (MVEC) seeded on 10 cm plates were grown to 80% confluence and then placed in serum-free medium. Similarly, cells growing in suspension culture (U937, Jurkat, HSB-2, and K562) were resuspended in serum-free medium at 3x10 6 cells/ml.
After 24 hours conditioned media (CM) from the cell cultures was harvested and concentrated 10 fold using a centrifugal filter device (Millipore Corp., Bedford, MA).
Aliquots of concentrated CM were digested with 5 units PNGase F (New England
Biolabs, Ipswich, MA) for 2 hours at 37 0 C. To prepare cell extracts, cells were washed once in PBS and then resuspended in Mer lysis buffer consisting of 50 mM HEPES pH7.5, 150 mM NaCl, 10 mM EDTA, 10% glycerol and 1% Triton X-100 supplemented with 0.1 mM sodium molybdate, 1 mM sodium orthovanadate and a protease inhibitor cocktail (Roche Diagnostics, Indianapolis, IN). Nuclei and membranes were removed by centrifugation. Cleared cell lysates and CM samples were analyzed by SDS-PAGE and immunoblotting.
Human and mouse tissues and primary cells
Mouse serum was prepared from blood collected from the tail vein. To elicit accumulation of macrophages in the peritoneal cavity, mice were injected intraperitoneally with 1 ml 3% thioglycollate (Sigma-Aldrich, St. Louis, MO). 3 days after thioglycollate injection mice, peritoneal macrophages were recovered by lavage. Human monocytes were isolated from peripheral blood by percol-gradient centrifugation followed by adherence to tissue culture-treated plates for 1.5 hrs under serum free conditions. Non-adherent cells were washed off and monocytes were cultured in X-VIVO 10 medium (Cambrex) supplemented with 10% pooled human serum for 7 days to allow differentiation into macrophages. The medium was then removed and replaced with X-VIVO medium without serum. Cells were incubated at 37 0 C overnight, and conditioned media and cells were analyzed by immunoblotting. Cells were visualized using a Leica DMRXMA microscope (Leica Microscopes, Allendale, NJ) and data was collected and processed using SlideBook The data were fit with a mixed model (SAS, PROC MIXED). The outcome was phagocytic index. The predictor was treatment, which was analyzed two ways: (i) as a class variable, and (ii) as a continuous variable. For (i), treatment levels were further compared using Dunnett's procedure.
Platelet aggregation
Blood was drawn into plastic syringes containing 3.2% buffered sodium citrate using a ratio of 9 parts whole blood to 1 part citrate anticoagulant. The whole blood was centrifuged using 135 x g for 10 minutes at room temperature to prepare platelet rich plasma (PRP). The PRP was removed and platelet count determined on a Cell-Dyn 4000 (Abbott Diagnostics, Abbott Park, IL). The remaining plasma and cells were centrifuged again at 1500 x g for 15 minutes at room temperature to prepare platelet poor plasma (PPP).
The PPP was used to dilute the PRP to a final platelet concentration of 200,000/ml. All aggregation studies were performed on a Platelet Aggregation Profiler For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From (0.029mg/kg) in a total volume of 50 μl was injected into the tail vein and mice were anesthetized with sodium pentobarbital (60 mg/kg, intraperitoneally). Mortality within 60 minutes after injection was assessed. Lungs were harvested, fixed in formalin overnight, and then sectioned and stained with hematoxylin and eosin.
Results
Ectodomain shedding of the Mer protein
Membrane-bound Mer in macrophage/monocyte cell lines was detected at 205kD in mouse J774 cells ( Figure 1A ) and human U937 cells ( Figure 1B) , consistent with previous reports of Mer protein size in U937 cells. 28 Mer extracellular domain with an apparent molecular weight of 140kD to 150kD was constitutively shed from J774 and U937 cells and accumulated in the culture medium. Mer is heavily glycosylated in the extracellular domain due to the presence of 13 potential N-linked glycosylation sites. 2 When the Mer ectodomain was treated with protein N-glycosidase F (PNGase F) to remove N-glycosylation, the Mer protein detected in the conditioned media was 65kD, similar to the predicted size based on amino acid sequence of the extracellular domain.
sMer was released into the medium from all cultured cell lines tested that express membrane-bound Mer. The shed Mer ectodomain was detected at different molecular weights in the media from different cell lines ( Figure 1C ). To demonstrate that the size differences noted in the shed Mer ectodomain are due to differences in glycosylation, we treated the U937 and HSB-2 Mer ectodomains (150kD and 125kD respectively) with
PNGase. After removal of N-linked glycosylation, the shed Mer ectodomain migrated at the same size in both of these cell lines ( Figure 1D ).
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In addition to detecting the Mer ectodomain in conditioned media from cultured lines, we found sMer in conditioned media from mouse peritoneal macrophage and spleen primary cells (Figure 2A) Figure 2B ). sMer was also abundant in human plasma obtained commercially as plasma pooled from normal donors ( Figure 2B ). Free-flowing plasma drawn in manner to minimize coagulation was also obtained from a normal donor to confirm that sMer was present in both human plasma and serum. There was no apparent increase in sMer noted following clotting of the plasma and analysis of the serum. Shedding of membranebound Mer from monocytes/macrophages, platelets, and endothelial cells likely contributes to sMer present in plasma.
PMA and LPS increase proteolytic cleavage of Mer
Ectodomain shedding of proteins can often be accelerated in the presence of PMA or LPS. 30 After treatment of J774 cells with 100ng/ml LPS for 4 hours or 50nM PMA for For For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From detected was a result of protease cleavage is shown in Figure 4B . Treatment with EDTA, which chelates cations necessary for metalloprotease function, partially inhibited LPSinduced shedding of Mer. In addition, LPS-induced shedding was virtually eliminated in the presence of the inhibitor TAPI-0 (tumor necrosis factor α protease inhibitor-0).
TAPI-0
31-34 is an inhibitor of TACE (tumor necrosis factor α converting enzyme), a member of the ADAM family 35 of metalloproteases, which cleaves the membrane bound precursor form of TNF-α to generate soluble TNF-α. The related Axl protein has been shown to be cleaved by TACE 36 as well as by ADAM10 37 . The inhibition of LPS shedding by TAPI-0 suggests that membrane-bound Mer, like Axl, can be cleaved by TACE or a TACE-like protease to generate sMer.
Soluble Mer binds and sequesters Gas6
Receptor shedding occurs by cleavage in a region immediately amino terminal to the transmembrane region. 38 Many shed receptors can effectively bind the ligand for the membrane-bound receptor and, consequently, prevent activation of the membrane-bound receptor. 27, [38] [39] [40] Endogenous sMer from the serum of wild type mice was able to bind Figure 5D ). 41 As the related Axl and Tyro-3 transmembrane receptors also bind Gas6, we analyzed mouse and human plasma for the presence of soluble forms of these receptors.
Consistent with previously published results from other groups, 37, 42, 43 soluble Axl (sAxl) glycoforms were detected in mouse and human plasma ranging in size from 65-80 kD (data not shown). In contrast, soluble Tyro-3 could not be detected in human plasma (data not shown). Similar to our findings with sMer, sAxl was capable of binding Gas6 37 and an Axl/Fc construct was able to block Gas6 mediated activation of full-length Mer (data not shown). Thus, sMer and sAxl both have the capability of sequestering Gas6 and preventing Gas6 mediated signaling.
Soluble Mer inhibits clearance of apoptotic cells
Mer is required for the normal function of macrophages to efficiently clear apoptotic cells. Macrophages from Mer KD mice display a profound defect in apoptotic cell engulfment. 21, 44 This phenomenon is believed to contribute to the development of a lupus-like autoimmunity in Mer 
Discussion
Membrane-bound receptors generate soluble receptors using alternative mRNA splicing to remove the transmembrane region or through proteolytic cleavage and release of the receptor ectodomain. Proteolytic cleavage has been found to regulate the activity and number of cytokine receptors, the density of cell surface adhesion molecules, and the release of soluble growth factors. 40 We now report that the receptor Mer tyrosine kinase can be proteolytically cleaved by a metalloprotease to produce a soluble Mer receptor, capable of binding the ligand Gas6.
Inhibition of Mer shedding with TAPI-0 suggests that the protease responsible for cleavage of the extracellular domain of the Mer receptor tyrosine kinase is TACE (ADAM17). TACE was the first member of ADAM family to be characterized 35 due to its ability to cleave the membrane-bound precursor form of TNF-α, releasing the soluble TNF-α from cells. Using mass spectrometric analysis of tryptic fragments differentially evident in TACE +/+ versus TACE -/-cell lines, TACE has also been shown to process the Mer related protein, Axl, as well as other proteins. 34 Primary amino acid sequence of the membrane proximal or "stalk" region is not crucial as stalk length for TACE cleavage. [45] [46] [47] [48] The defined TACE cleavage site in Axl is a 14 amino acid region 18 only.
For For 21, 44 supporting the concept that failure to remove apoptotic cells may provide an immunogenic stimulus for autoimmune disease. Our data suggests that sMer plays a role in regulating macrophage clearance of apoptotic cells. Additional studies will be necessary to determine if sMer levels are altered in patients with autoimmune disease.
In a similar manner, we use platelets to demonstrate that sMer directly affects the activity of full-length Mer in another cell type and that this specific tyrosine kinase inhibition significantly alters cell function. Mer is known to be important in normal platelet function since mice lacking a Mer receptor 26 or Gas6 25 have diminished platelet aggregation in response to agonist. In this report we demonstrate that sMer has a similar effect on platelet aggregation in vitro and, furthermore, the dysfunctional platelet aggregation leads to an effect on clot stability in vivo as wildtype mice were protected against collagen/epinephrine induced pulmonary thromboembolism. These findings are consistent with reports that Mer KD and Gas6 -/-mice have in vivo protection from collagen/epinephrine induced pulmonary thromboembolism and inhibition of ferric chloride induced thrombosis 25, 26 . In both animal models, the protective effects of platelet For personal use at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From
